BioVenture VoiCes with Chris Garabedian

BiotechTV

Hosted by Chris Garabedian, meet the leading Voices in the BioVenture community and hear their insights and perspectives on the challenges and successes with VC investing.

Listen in podnod RSS feed Show website

43 episodes
Updated Monday

Episodes43

Newest first

Monday · 1 hr 12 min
Episode 44: BainCapital's Adam Koppel
Adam Koppel describes his career path, which included a stop at McKinsey, Biogen, and twice at Bain (where he is now). He descrbies the private equity model they have been on the leading edge of, and his take on where we are in the biotech cycle. Plus, the critical importance of mentors.
July 13 · 1 hr 7 min
Episode 43: Lightstone Venture's Mike Carusi
Mike Carusi describes his early life and career, how gaining an appreciation for sales made an impression on him early on, and his philosophy of investing in medical devices - and the similarities and differences between that and investing in therapeutics.
June 15 · 1 hr 5 min
Episode 42: Nextech's Thilo Schroeder
Having been an early investor in many recent successes such as Revolution Medicines, Peloton, and Parabilis Medicines, he describes his investment philosophy and focus on precision oncology companies. Plus, his early life, getting hands on experience in biotech at Micromet, and learning from some of the top investors and scientific advisors in the industry.
June 1 · 1 hr 2 min
Episode 41: Forbion's Nanna Lüneborg
Nanna Luneborg discusses hear career and joining Forbion. She describes the firm's investment approach, and her experience with everything from seed, to private, and to public investing in life sciences. Plus, thoughts on China and AI in biotech.
May 18 · 1 hr 19 min
Episode 40: GV's Krishna Yeshwant
He describes his well-rounded background of studying and working in both software in Silicon Valley and Medicine in Boston, and the start of GV. He describes a conservative start to investing at GV, but also today how Alphabet's scale and cash gives them the ability to ride cycles and make concentrated bets on companies the team has conviction on.
May 4 · 1 hr 12 min
Episode 39: SV Health Investors' Kate Bingham
Kate Bingham describes her early life and a serendipitous opportunity to work at Vertex in the early 1990's. She then discusses joining SV Health and describes its investment approaches, the Dementia Discovery Fund, being on the UK's Vaccine Taskforce during Covid, and more.
April 20 · 1 hr 5 min
Episode 38: Deerfield Management's Jason Fuller
He discusses his education and joining the Langer Lab at MIT, early experiences in venture, including at Third Rock and NEA, and gaining operational experience at Jounce before joining Deerfield. Plus, areas that interest him today and how he thinks about AI.
March 23 · 1 hr 6 min
Episode 37: SR One's Simeon George
Simeon George discusses his early days at SR One while it was part of GSK, and the transition to making the firm independent in 2020. Plus, the importance of peer-to-peer collaboration, and his how he thinks about investing in different indications and modalities.
March 9 · 1 hr 1 min
Episode 36: Sofinnova Invetments' Jim Healy
He discusses learnings from his decades in venture at Sofinnova Investments including 'products vs platform', therapeutics areas of interest, modalities, and how he utilizes board seats and thinks about management teams.
February 23 · 1 hr 9 min
Episode 35: INITIATE Ventures' Jessica Owens
Jessica Owens discusses the many experiences she has had in her career, including working on the venture side at Kleiner Perkins and Versant Ventures and on the operating side at Genomic Health and Grail. She highlights the value of VCs being able to understand how operators like CEOs think, and describes the type of investing INITIATE focuses on.
February 9 · 1 hr 7 min
Episode 34: General Atlantic's Brett Zbar
Brett Zbar describes his early career, including working at Aisling Capital and Foresight Capital, and now managing the healthcare strategy at General Atlantic. He describes how he sees the difference between private equity and venture capital, and discusses which themes in biotech and healthcare appeal to him today.
January 26 · 58 min
Episode 33: Pappas Capital's Art Pappas
Art Pappas describes his early career, which involved numerous overseas posts for large companies, and how it let him to eventually found Pappas Capital. He discusses the various ways the firm invests, and how having corporates partners as LPs and co-investors has been a recipe for success.
January 11 · 1 hr 15 min
Episode 32: ARCH Venture Partners' Bob Nelsen
While describing his early life in Washington and formative years at the University of Chicago that led to the founding of ARCH, he shares his thoughts on leadership, risk taking, changes he thinks are need to keep the United States competitive in life sciences, and his belief in AI's promise to transform our industry.
Dec 29, 2025 · 1 hr 2 min
Episode 31: Polaris Partners' Amy Schulman
She describes her career beginnings as a lawyer, which led to general counsel and business unit head roles at Pfizer, and then joining the VC world at Polaris Partners (at Bob Langer's urging). She discusses the firm's investment philosophy, the nuances behind how companies choose lead assets, and the cycles biotech has been through over the last ten years. Plus, other roles she currently serves, including being the chair of Alnylam.
Dec 1, 2025 · 1 hr 19 min
Episode 29: Averin Managing Partner David Berry
He describes his early life and education, 18 years of company building at Flagship Pioneering, founding Averin (previously called Bedford Bridge) with his brother, and investing at the intersection of healthcare and technology.
Nov 10, 2025 · 1 hr
Episode 28: Hatteras Venture Partners' Clay Thorp
Clay Thorp describes his early education and becoming a business partner to his brother on a genomics startup. He describes the genesis of Hatteras, the history and strengths of the life sciences ecosystem in the North Carolina area, and his philosophy of backing founders.
Oct 20, 2025 · 1 hr 3 min
Episode 27: Avalon Bioventures' Jay Lichter
Jay Lichter describes his roots growing up in Chicago, Yale, and an early career role at DuPont Merck before getting a call from Kevin Kinsella to try the world of venture at Avalon. Since that pivotal move, he describes numerous companies he either operated or funded, leading to his work today at Avalon Bioventures.
Oct 6, 2025 · 1 hr 21 min
Episode 26: venBio's Corey Goodman
Corey Goodman shares learnings for his career in biotech, including working in academia, biotech, pharma, and as a venture capital investor. He describes the unique learnings from all of them and why he is thankful that he has experienced these different components of life sciences.
Sep 22, 2025 · 1 hr 18 min
Episode 25: Atlas Venture's Bruce Booth
Bruce Booth discusses his education and early career, the structure of Atlas and the types of investments it makes, investing in assets vs platforms, and more.
Aug 11, 2025 · 1 hr 12 min
Episode 24: Samsara Biocapital's Srini Akkaraju
The Founder & Managing Partner of Samsara Biocapital, Dr. Akkaraju describes his early move from Standford to industry and various investment firms he worked for before founding Samsara in 2016. He discusses how the firm invests in all stages of life sciences companies and why he believes patience is a key virtue.

BioVenture VoiCes with Chris Garabedian

Episode 44: BainCapital's Adam Koppel

Episode 43: Lightstone Venture's Mike Carusi

Episode 42: Nextech's Thilo Schroeder

Episode 41: Forbion's Nanna Lüneborg

Episode 40: GV's Krishna Yeshwant

Episode 39: SV Health Investors' Kate Bingham

Episode 38: Deerfield Management's Jason Fuller

Episode 37: SR One's Simeon George

Episode 36: Sofinnova Invetments' Jim Healy

Episode 35: INITIATE Ventures' Jessica Owens

Episode 34: General Atlantic's Brett Zbar

Episode 33: Pappas Capital's Art Pappas

Episode 32: ARCH Venture Partners' Bob Nelsen

Episode 31: Polaris Partners' Amy Schulman

Episode 29: Averin Managing Partner David Berry

Episode 28: Hatteras Venture Partners' Clay Thorp

Episode 27: Avalon Bioventures' Jay Lichter

Episode 26: venBio's Corey Goodman

Episode 25: Atlas Venture's Bruce Booth

Episode 24: Samsara Biocapital's Srini Akkaraju